Hide Board Information

Show Board Information

Raphael Pharmaceutical Inc RAPH

Board Mod: louied91

Asst Mods:

Last Post: 01/07/2025 9:20:00 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

Raphael Pharmaceutical Inc. (“Raphael”) (OTCQB: RAPH) is a clinical-stage biotechnology company focused on advancing a novel cannabinoid-based research platform for the treatment of various inflammatory diseases. Raphael’s lead product candidate is a highly purified cannabinoid formulation specifically developed for the treatment of rheumatoid arthritis.

For more information, please visit https://www.raphaelpharmaceutical.com/.

Raphael Pharmaceutical Inc (OTCMRKTS: RAPH) Stock Message Board

1. RAPH Company Profile

    

2. RAPH Time & Sales

    

3. RAPH Recent News

    

4. RAPH Filings

    

5. RAPH Financials

    

6. RAPH Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1

$RAPH Raphael Pharmaceutical Announces Positive

louied91

01/07/2025 9:20:00 AM

Recent Articles

• Smart Office Innovations Driving Market Growth to USD 122.50 Billion
• Exploring the Growth and Potential of Robotic Vision Industry
• Exploring Trends in Medical Terminology Software Growth
• Exploring Growth Factors in the Track and Trace Solutions Market
• Accelerating Growth in the Microduct Market: A Future Vision
• Netcompany Group A/S Enhances Capital Structure with Share Buyback
• Football Fandom and Heart Health: A Growing Concern
• Marimekko's Commitment to Sustainability Gains Recognition
• Redfin Observes Shifting Trends in U.S. Housing Market Costs
• Independent Bank Corporation Achieves Notable 2024 Growth
• Suburban Propane Partners, L.P. Announces New Distribution Rate
• PPL Corporation to Host Webcast for 2024 Financial Results
• Celebrating 30 Years of Luxury Travel Excellence with Cadence
• Rockwell Automation Launches Cutting-Edge Research Facility
• Jacobs Awarded Significant US Army Corps Contract in Asia
• Exploring the Future of Hydrogen Fuel Cell Trains and Their Market
• Belo Sun Mining Secures Permitting Progress for Gold Project
• Ryman Hospitality Properties Expands Meeting Space at Gaylord Opryland
• American Tungsten Corp. Transforms Identity with Name Change
• Stardust Power Launches Major Lithium Refinery Project
• Tim Bowes Takes the Helm as Axalta's Industrial Coatings Chief
• Incannex Healthcare's Promising Advances in Sleep Apnea Treatment
• Laser Photonics Enhances R&D for Advanced Laser Technologies
• Stock Yards Bancorp Gears Up for Upcoming CEO Forum Events
• Red Cat Wins Major Drone Orders Reinforcing Government Trust
• Applied Materials Set to Announce Q1 2025 Earnings Soon
• ESAB Corporation Announces Upcoming Fourth Quarter Earnings Date
• Biogen's Higher Dose Nusinersen Application Gains Approval
• Organon Prepares to Reveal Q4 2024 Financial Insights Soon
• Tintina Mines Presents Promising Resource Estimate for Domeyko
• Perion Network Set to Reveal Fourth Quarter Earnings Details
• Nykredit Realkredit A/S Updates Euro Medium Term Note Details
• Real Brokerage Celebrates Milestone with 25,000 Agents
• MediaBrain Welcomes Carol Hinnant to Its Board of Directors
• Northern Trust Corporation Unveils Impressive Q4 Financials
• Tribridge Residential Unveils Innovative AI Solution for 6200 Units
• IonQ Partners with Busan to Revolutionize Quantum Computing
• Lithium Argentina AG Completes Migration to Switzerland for Growth
• Empowering Black Entrepreneurs: Launch of BBE Certification
• Veeva and Zifo's Strategic Collaboration to Enhance QC
• Cyngn's Innovative Solutions Foster Automation in Auto Sector
• Porter Capital Completes $20 Million Financing for Healthcare Staffing
• Annington Funding PLC's Major Debt Reduction and Dividend News
• FNA Group Expands Market Reach with Kent Acquisition
• Draganfly Secures FAA Approval for Drone Operations in Urban Areas
• V2X, Inc. Set to Release Fourth Quarter 2024 Results Soon
• Vantis Vascular's CrossFAST System Revolutionizes Cardiac Procedures
• Accuray Celebrates Milestone with Tomo C System in Patient Care
• EU Commission Explores Solidarity for Stablecoin Investors
• American Airlines Faces Challenges Ahead in Profit Forecasts